Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.47% to 1,321.20 Indian rupees Thursday, on what proved to be an all-around ...

Citi believes that market expectations for the GLP-1 opportunity in Canada may be too optimistic, based on its latest deep ...

Dr. Reddy's Laboratories Ltd. closed 5.59% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Shares of Dr Reddy's Laboratories decreased by 2 per cent to Rs 1,317 in morning trading, following Citi Research's decision ...

Citi expressed caution on the growth outlook, particularly around the Canadian GLP-1 market and the highly anticipated launch ...

The scrip traded higher than the 5-day, 10-, 20-, 30-, 50-, 100-, 150-day and 200-day simple moving averages (SMAs).

Ahmedabad: Intas Pharma has announced the appointment of Rambabu Ogirala as Associate Vice President - Manufacturing ...

Discover the Dr Reddys Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize ...

Senior joint replacement surgeon of Sai Bhaskar Multi speciality hospital Dr Busireddy Narendra Reddy said Russians were ...

Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...